Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2
- PMID: 8806506
- DOI: 10.1006/viro.1996.0417
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2
Abstract
An infectious molecular clone was derived from the HIV-2UC2 isolate that previously was found to persistently infect and induce an AIDS-like disease syndrome in baboons. The molecularly cloned virus (HIV-2UC2mc) showed in vitro properties similar to those of the parental isolate with regard to T-cell tropism, cytopathicity, and the ability to infect primary baboon PBMC. Nevertheless, when inoculated into two baboons, the cloned virus showed a limited ability to replicate in these animals. DNA sequence analysis revealed a defective vpr gene in the UC2mc as well as in the pathogenic parental UC2 strain. Thus, the vpr gene is not required for the induction of disease in baboons. The attenuated infectious molecular clone of UC2 should be useful for future studies designed to map the genetic determinants of HIV-2 pathogenesis in the baboon model and to evaluate vaccine strategies.
Similar articles
-
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives.Virology. 2004 Sep 1;326(2):329-39. doi: 10.1016/j.virol.2004.05.027. Virology. 2004. PMID: 15321704
-
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans.Arch Pathol Lab Med. 1998 Jun;122(6):523-33. Arch Pathol Lab Med. 1998. PMID: 9625420
-
Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.Virology. 1999 Aug 1;260(2):295-307. doi: 10.1006/viro.1999.9812. Virology. 1999. PMID: 10417264
-
Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.Immunol Rev. 2001 Oct;183:127-40. doi: 10.1034/j.1600-065x.2001.1830111.x. Immunol Rev. 2001. PMID: 11782253 Review.
-
Human immunodeficiency virus type 2: human biology of the other AIDS virus.Curr Clin Top Infect Dis. 1996;16:84-101. Curr Clin Top Infect Dis. 1996. PMID: 8714249 Review. No abstract available.
Cited by
-
Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro.Antimicrob Agents Chemother. 2008 Jan;52(1):329-32. doi: 10.1128/AAC.01004-07. Epub 2007 Oct 29. Antimicrob Agents Chemother. 2008. PMID: 17967913 Free PMC article.
-
Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.J Virol. 1997 Sep;71(9):6296-304. doi: 10.1128/JVI.71.9.6296-6304.1997. J Virol. 1997. PMID: 9261346 Free PMC article.
-
Non-human primate models for AIDS vaccine research.Curr Drug Targets Infect Disord. 2005 Jun;5(2):193-201. doi: 10.2174/1568005054201508. Curr Drug Targets Infect Disord. 2005. PMID: 15975024 Free PMC article. Review.
-
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.Retrovirology. 2016 Dec 20;13(1):85. doi: 10.1186/s12977-016-0320-7. Retrovirology. 2016. PMID: 27998283 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources